C9orf173-AS1


c9orf173-as1: Unraveling the Role of a Gene Associated with Neurodegenerative Diseases

Description

c9orf173-as1 is a long non-coding RNA (lncRNA), a type of genetic material that regulates gene expression without coding for proteins. It is located on chromosome 9 and spans approximately 100,000 base pairs. LncRNAs play crucial roles in various cellular processes, including gene expression, chromatin remodeling, and cell differentiation.

Associated Diseases

c9orf173-as1 has been implicated in several neurodegenerative diseases, including:

  • Amyotrophic lateral sclerosis (ALS): ALS is a fatal disorder characterized by progressive degeneration of motor neurons, leading to muscle weakness and paralysis. Studies have shown that dysregulation of c9orf173-as1 contributes to ALS pathogenesis by disrupting the normal function of motor neurons.
  • Frontotemporal dementia (FTD): FTD is a group of degenerative brain disorders that affect the frontal and temporal lobes, resulting in cognitive and behavioral changes. Variants in c9orf173-as1 have been linked to certain types of FTD, including familial FTD with motor neuron disease.
  • Alzheimer's disease (AD): AD is the most common form of dementia, characterized by memory loss and cognitive decline. While the exact role of c9orf173-as1 in AD is still being investigated, studies suggest it may be involved in disease progression through mechanisms related to inflammation and neuronal damage.

Did you Know ?

Mutations in c9orf173-as1 have been identified in approximately 1-2% of ALS patients and 5-10% of familial FTD cases. This highlights the significant role of this gene in the development of these neurodegenerative diseases.



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.